Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

DECHRA PHARMACEUTICALS LIMITED

Company number 03369634

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 May 2023 SH01 Statement of capital following an allotment of shares on 12 May 2023
  • GBP 1,138,841.41
05 May 2023 SH01 Statement of capital following an allotment of shares on 4 May 2023
  • GBP 1,138,797.78
15 Mar 2023 SH01 Statement of capital following an allotment of shares on 14 March 2023
  • GBP 1,138,492.78
03 Jan 2023 AP01 Appointment of Ms Geeta Gopalan as a director on 1 January 2023
22 Dec 2022 SH01 Statement of capital following an allotment of shares on 14 December 2022
  • GBP 1,138,365.81
28 Oct 2022 AA Group of companies' accounts made up to 30 June 2022
28 Oct 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES10 ‐ Resolution of allotment of securities
15 Sep 2022 SH01 Statement of capital following an allotment of shares on 9 September 2022
  • GBP 1,137,669.75
05 Sep 2022 TM01 Termination of appointment of Julian Spenser Heslop as a director on 5 September 2022
26 Jul 2022 SH01 Statement of capital following an allotment of shares on 25 July 2022
  • GBP 1,137,638.38
25 Jul 2022 SH01 Statement of capital following an allotment of shares on 12 July 2022
  • GBP 1,083,991.55
04 Jul 2022 SH01 Statement of capital following an allotment of shares on 24 June 2022
  • GBP 1,083,927.37
01 Jun 2022 AP01 Appointment of Mr John Francis Shipsey as a director on 1 June 2022
18 May 2022 CS01 Confirmation statement made on 13 May 2022 with no updates
17 May 2022 TM01 Termination of appointment of William Anthony Rice as a director on 31 December 2021
12 May 2022 SH01 Statement of capital following an allotment of shares on 13 April 2022
  • GBP 1,083,894.45
18 Mar 2022 SH01 Statement of capital following an allotment of shares on 10 March 2022
  • GBP 1,083,883.05
21 Jan 2022 SH01 Statement of capital following an allotment of shares on 13 December 2021
  • GBP 1,083,647.04
13 Dec 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 13 September 2021
  • GBP 1,082,226.39
02 Dec 2021 TM01 Termination of appointment of Denise Elaine Goode as a director on 30 November 2021
02 Nov 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES13 ‐ General meetings called 21/10/2021
  • RES10 ‐ Resolution of allotment of securities
28 Oct 2021 AA Group of companies' accounts made up to 30 June 2021
15 Sep 2021 SH01 Statement of capital following an allotment of shares on 13 September 2021
  • GBP 1,082,226.39
  • ANNOTATION Clarification a second filed SH01 was registered on 13/12/2021
01 Jul 2021 SH01 Statement of capital following an allotment of shares on 25 June 2021
  • GBP 1,082,153.23
14 May 2021 CS01 Confirmation statement made on 13 May 2021 with no updates